首页> 外文期刊>Trials >Standardised Outcomes in Nephrology – Chronic Kidney Disease (SONG-CKD): a protocol for establishing a core outcome set for adults with chronic kidney disease who do not require kidney replacement therapy
【24h】

Standardised Outcomes in Nephrology – Chronic Kidney Disease (SONG-CKD): a protocol for establishing a core outcome set for adults with chronic kidney disease who do not require kidney replacement therapy

机译:肾病中的标准化结果 - 慢性肾病(SONG-CKD):用于建立成人核心成果的核心结果,患有慢性肾脏疾病的成人,患者不需要肾置换疗法

获取原文
       

摘要

Globally, over 1.2 million people die from chronic kidney disease (CKD) every year. Patients with CKD are up to 10 times more likely to die prematurely than progress to kidney failure requiring kidney replacement therapy. The burden of symptoms and impaired quality of life in CKD may be compounded by comorbidities and treatment side effects. However, patient-important outcomes remain inconsistently and infrequently reported in trials in patients with CKD, which can limit evidence-informed decision-making. The Standardised Outcomes in Nephrology – Chronic Kidney Disease (SONG-CKD) aims to establish a consensus-based core outcome set for trials in patients with CKD not yet requiring kidney replacement therapy to ensure outcomes of relevance to patients, caregivers and health professionals are consistently reported in trials. SONG-CKD involves four phases: a systematic review to identify outcomes (domains and measures) that have been reported in randomised controlled trials involving adults with CKD who do not require kidney replacement therapy; stakeholder key informant interviews with health professionals involved in the care of adults with CKD to ascertain their views on establishing core outcomes in CKD; an international two-round online Delphi survey with patients, caregivers, clinicians, researchers, policy makers and industry representatives to obtain consensus on critically important outcome domains; and stakeholder consensus workshops to review and finalise the set of core outcome domains for trials in CKD. Establishing a core outcome set to be reported in trials in patients with CKD will enhance the relevance, transparency and impact of research to improve the lives of people with CKD. Not applicable. This study is registered with the Core Outcome Measures in Effectiveness Trials (COMET) database: http://www.comet-initiative.org/Studies/Details/1653 .
机译:在全球范围内,每年来自120万人死于慢性肾病(CKD)。患有CKD的患者高达10倍的可能性,而不是需要肾功能衰竭治疗的进展。 CKD中症状和生命损害的负担可以通过合并症和治疗副作用复合。然而,患者的重要结果在CKD患者的试验中仍然不一致,常常报告,这可能会限制证据明智的决策。肾病中的标准化结果 - 慢性肾病(Song-CKD)旨在建立一种基于CKD患者试验的基于共识的核心结果,尚不需要肾置换疗法,以确保与患者,护理人员和卫生专业人员相关的相关性,这是一致的在试验中报告。宋 - CKD涉及四个阶段:系统审查,以识别涉及涉及患有肾脏替代治疗的成年人的随机对照试验中的结果(领域和措施);利益攸关方与卫生专业人士的关键信息面试,参与CKD的成年人的照顾,以确定他们在CKD中建立核心结果的看法;与患者,护理人员,临床医生,研究人员,政策制定者和行业代表进行国际双轮在线德尔福调查,以获得批判性重要成果领域的共识;和利益相关者共识讲习班,审查和最终确定CKD中试验的核心成果领域。在CKD患者试验中建立核心结果组将提高研究的相关性,透明度和影响,以改善CKD人民的生命。不适用。本研究在有效试验中的核心结果措施(COMET)数据库中注册:http://www.comet-initiative.org/studies/details/1653。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号